A Functional Precision Medicine Pipeline Combines Comparative Transcriptomics and Tumor Organoid Modeling to Identify Bespoke Treatment Strategies for Glioblastoma.
Cells
Reed, Megan R MR; Lyle, A Geoffrey AG; De Loose, Annick A; Maddukuri, Leena L; Learned, Katrina K; Beale, Holly C HC; Kephart, Ellen T ET; Cheney, Allison A; van den Bout, Anouk A; Lee, Madison P MP; Hundley, Kelsey N KN; Smith, Ashley M AM; DesRochers, Teresa M TM; Vibat, Cecile Rose T CRT; Gokden, Murat M; Salama, Sofie S; Wardell, Christopher P CP; Eoff, Robert L RL; Vaske, Olena M OM; Rodriguez, Analiz A
A Functional Precision Medicine Pipeline Combines Comparative Transcriptomics and Tumor Organoid Modeling to Identify Bespoke Treatment Strategies for Glioblastoma.
Cells
Reed, Megan R MR; Lyle, A Geoffrey AG; De Loose, Annick A; Maddukuri, Leena L; Learned, Katrina K; Beale, Holly C HC; Kephart, Ellen T ET; Cheney, Allison A; van den Bout, Anouk A; Lee, Madison P MP; Hundley, Kelsey N KN; Smith, Ashley M AM; DesRochers, Teresa M TM; Vibat, Cecile Rose T CRT; Gokden, Murat M; Salama, Sofie S; Wardell, Christopher P CP; Eoff, Robert L RL; Vaske, Olena M OM; Rodriguez, Analiz A
TSC1/2 mutations define a molecular subset of HCC with aggressive behaviour and treatment implication.
Gut
Ho, Daniel W H DWH; Chan, Lo K LK; Chiu, Yung T YT; Xu, Iris M J IMJ; Poon, Ronnie T P RTP; Cheung, Tan T TT; Tang, Chung N CN; Tang, Victor W L VWL; Lo, Irene L O ILO; Lam, Polly W Y PWY; Yau, Derek T W DTW; Li, Miao X MX; Wong, Chun M CM; Ng, Irene O L IOL